Reuters Fact-Checks: Pfizer Vaccine Not Linked to Hantavirus

A recent wave of misinformation has sought to link the widely used Pfizer-BioNTech COVID-19 vaccine to Hantavirus Pulmonary Syndrome (HPS). This dangerous falsehood, amplified across social media platforms like Facebook and X, falsely suggests a connection based on a misinterpretation of documents submitted to the U.S. Food and Drug Administration (FDA).

These claims twist the reporting of adverse events during vaccine development. As Pfizer representatives have clarified, all medical occurrences experienced by trial participants are documented, irrespective of whether they are causally related to the vaccine. The mere inclusion of an event in such a list does not equate to the vaccine causing it. This is a standard procedure in clinical trials, designed to capture all reported health issues for thorough review.

“

The claim that the Pfizer COVID-19 vaccine causes Hantavirus Pulmonary Syndrome is false.

Reuters' fact-checking arm has rigorously investigated these allegations and confirmed them to be baseless. Hantavirus Pulmonary Syndrome is not among the vaccine's confirmed side effects. This incident highlights the persistent challenge of combating health-related disinformation, particularly concerning vaccines that have been instrumental in global public health efforts. It is crucial for the public to rely on credible sources and verified information to avoid unnecessary fear and confusion.

“

Any medical event experienced by vaccine trial participants is listed, regardless of whether it is related to the vaccine, and anyone can report an adverse event. This does not mean the vaccine caused such health problems.